Rosetta Genomics Ltd. (USA) Stock Nasdaq
Equities
IL0011026494
Biotechnology & Medical Research
Financials (USD)
Sales 2015 | 8.27M | Sales 2016 | 9.23M | Capitalization | 9.22M |
---|---|---|---|---|---|
Net income 2015 | -17M | Net income 2016 | -16M | EV / Sales 2015 | 1.07 x |
Net cash position 2015 | 13.54M | Net cash position 2016 | 2.45M | EV / Sales 2016 | 0.73 x |
P/E ratio 2015 |
-1.07
x | P/E ratio 2016 |
-0.54
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ron Kalfus
DFI | Director of Finance/CFO | 50 | 12-05-23 |
Nicole Massoll
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 09-12-21 |
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |